ArticleScience advances2025

Lyn restrains lupus via kinase-independent mechanisms that limit Toll-like receptor activation and type I interferon responsiveness.

Elan L'Estrange-Stranieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.